Nuwellis Expected to Post $1.56 Per Share Loss, Revenue Decline Ahead of March 10 Report
Summary
Nuwellis Inc is expected to report a significant loss of $1.56 per share for the quarter ending December 31, 2025, according to analyst estimates. The company is also projected to see a modest 0.5% decrease in revenue to $2.31 million. This earnings preview, indicating a loss per share greater than the current stock price, signals severe financial challenges for the micro-cap company. This news follows a recent 8-K filing on February 26, 2026, detailing a lawsuit against Nuwellis, further compounding negative sentiment. Traders will be closely watching the official earnings release on March 10 for confirmation of these dire expectations and any commentary on the company's financial stability and ongoing legal issues.
At the time of this announcement, NUWE was trading at $1.50 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.8M. The 52-week trading range was $1.40 to $56.28. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Reuters.